Skip to main content

Mark S Segal, MD, PhD : Research

Nephrologist (Kidney Specialist)

Photo of Mark S Segal
(352) 265-4845 MyUFHealth

Research at a glance

Top areas of exploration

  • Cells, Cultured , 26 publications
  • Kidney Failure, Chronic , 17 publications
  • Biomarkers , 17 publications
  • Hypertension , 15 publications

Research activity

175 publications

14,249 citations

Why is this important?

Active clinical trials

HyperQure RDN System

HQ-HTN-G01 is a prospective, multicenter, single arm, open label, early feasibility study to evaluate initial safety and device design concept of "HyperQureTM RDN System", laparoscopic renal denervation therapy, in patients with resistant…

Investigator
Mark S Segal
Status
Accepting Candidates
Ages
22 Years - 80 Years
Sexes
All
EASi-KIDNEY
Investigator
Mark S Segal
Status
Accepting Candidates
REGEN-006

The purpose of this study is to assess the safety and efficacy of up to 2 REACT/rilparencel injections in participants with T2DM and CKD.

Investigator
Mark S Segal
Status
Accepting Candidates
Ages
30 Years - 80 Years
Sexes
All

My publications

Filter publications

175 publications

2026

Outcomes Among Patients With End‑stage Kidney Disease and Chronic Limb‑threatening Ischemia: A Population‑based Cohort Study: Erratum.

Annals of surgery

PubMed • Publisher's site

2026

Outcomes Among Patients With End-stage Kidney Disease and Chronic Limb-threatening Ischemia: A Population-based Cohort Study.

Annals of surgery

PubMed • Publisher's site

2026

Correction to: Provision of Kidney Disease Education Service Is Associated with Improved Vascular Access Outcomes among US Incident Hemodialysis Patients.

Kidney360

PubMed • Publisher's site

2026

Gaps in Vascular Evaluation Before Major Lower-Extremity Amputation Among Medicare Beneficiaries With Chronic Limb-Threatening Ischemia.

medRxiv : the preprint server for health sciences

PubMed • Publisher's site

2025

Effectiveness and efficiency of an add-on active outreach strategy on research enrollments in a drug intervention trial.

Journal of clinical epidemiology

PubMed • Publisher's site